Big pharmas have maintained a torrid pace for accessing biotech innovation to help strengthen their product pipelines. As a result it was a great quarter for biotech deal making, according to data compiled by BioWorld Snapshots, seeing 81 transactions completed between biotech companies and pharma firms – approximately 19 percent more than the number of deals completed in the second quarter of this year. Read More
Smokers have plenty of options to quit, but many restart because of chronic "smoker's cough" caused by mucus buildup in the lungs that forms after they stop smoking. Read More
